As part of its restructuring that includes cutting about 9,000 employees globally, Novo Nordisk is laying off U.S. employees this week and continuing into next week. Reuters noted that based on an email it received, affected departments include HR, clinical development, rare diseases, medical and regulatory, legal, ethics and compliance, marketing and sales, finance and public affairs.
